Stock Movers

On this episode of Stock Movers:
- Shares in miner Fresnillo Mining jump as much as 4.2% due to the continued metal rally - International Personal Finance (IPF) rises as much as 6.8% in London trading after Basepoint agreed to buy the consumer finance company in a deal valuing IPF at about £543 million.
- Rheinmetall and other defense stocks are down after Trump said a lot of progress was made on Ukraine peace talks

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers, we look at some the week's biggest gainers and decliners:

- Warner Bros. Discovery (WBD) saw a modest weekly gain as Paramount continues to try to counter Netflix's bid to buy it. Larry Ellison is throwing his personal fortune behind Paramount Skydance’s bid for Warner Bros. Discovery Inc., aiming to give his son’s company an advantage in a fiercely contested takeover battle with Netflix. Both suitors moved on Monday to strengthen the financial backing for their offers, though they stopped short of increasing their bids. Netflix refinanced a portion of its planned $59 billion of debt as a way to ensure a lasting investment-grade rating — a key advantage it holds over the lower-rated Paramount.

- Sable (SOC) saw its shares skyrocket on word that a federal regulator approved the restart of Sable Offshore Corp.’s contested California oil pipeline that leaked 3,000 barrels of crude along the Santa Barbara coastline a decade ago. Sable’s shares rose about 30% Tuesday after it said its plan was signed off on by the Department of Transportation’s Pipeline and Hazardous Materials and Safety Administration. The move follows last week’s determination by the regulator that portions of the key oil conduit, the Las Flores Pipeline System, is under the domain of the federal government and not California. State environmental groups are poised to push back.

- Nvidia (NVDA) agreed to a licensing deal with artificial intelligence startup Groq, furthering its investments in companies connected to the AI boom and gaining the right to add a new type of technology to its products. The world’s largest publicly traded company has paid for the right to use Groq’s technology and will integrate its chip design into future products. Some of the startup’s executives are leaving to join Nvidia to help with that effort, the companies said. Groq will continue as an independent company with a new chief executive, it said Wednesday in a post on its website. Shares of Nvidia rallied on the news.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Warner Bros. Discovery (WBD) shares slid after a report from the New York Post that Paramount Skydance could walk away from its $30-per-share cash bid and instead litigate against the company’s board for how it handled the process.

- Sable Offshore (SOC) shares fell as much as 17% after the Environmental Defense Center and Center for Biological Diversity filed an emergency motion to halt the restart of a contested California oil pipeline.

- Target (TGT) shares rose on Friday after the Financial Times reported that an activist investor built up a stake in the big-box retailer, citing people it didn’t identify. Toms Capital Investment Management has made a significant investment in Target, the FT said, without disclosing further details. Target shares jumped as much as 6.7% on Friday. The stock is headed for an annual decline of about 25% following a difficult year in which the company lost market share and sales slumped.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Nvidia (NVDA) agreed to a licensing deal with artificial intelligence startup Groq, furthering its investments in companies connected to the AI boom and gaining the right to add a new type of technology to its products. The world’s largest publicly traded company has paid for the right to use Groq’s technology and will integrate its chip design into future products. The deal was reported on after the end of the trading day on Christmas Eve. Shares of Nvidia rallied when trading resumed on Friday.

- Shares of mining companies like Coeur (CDE) and Freeport (FCX) are higher in trading Friday as gold, silver and platinum jumped to all-time highs and copper surged to a record in Shanghai and rallied in New York. Spot gold rose as much as 1.2% to a peak above $4,530 an ounce on Friday. Spot silver for immediate delivery advanced for a fifth session, climbing as much as 5% to cross $75 an ounce.

- Tesla (TSLA)'s ’s door handles are facing renewed scrutiny in the US after federal auto safety regulators opened a probe into the emergency releases in certain Model 3 vehicles. The National Highway Traffic Safety Administration said it’s evaluating claims that the mechanical door release “is hidden, unlabeled, and not intuitive to locate during an emergency,” according to a filing on the agency’s website. The move stems from a petition filed by Kevin Clouse, a Tesla owner in Georgia who says he was trapped in his vehicle in 2023 and requested a defect investigation. NHTSA said it hasn’t decided whether to grant or deny the petition. Shares of the Elon Musk-run EV maker fell in trading on Friday.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Nvidia (NVDA) edge higher in the premarket session as the company agreed to a licensing deal with artificial intelligence startup Groq, furthering its investments in companies connected to the AI boom and gaining the right to add a new type of technology to its products.
- Shares of Indian technology services provider Coforge Ltd. (COFORGE IN) declined ahead of the US market open after the company agreed to buy Encora at an enterprise value of $2.35 billion in an all-stock deal, adding artificial intelligence, data and product engineering expertise. Encora’s shareholders, including Advent International and Warburg Pincus, will get about 20% stake in Coforge through a share swap. Coforge will issue 93.8 million shares at 1,815.91 rupees each to shareholders of Encora at equity value of $1.89 billion. The deal is expected to close in six months.
- Shares of Biohaven (BHVN) fell as much 14 percent in US premarket trading after a mid-stage study of the company’s experimental drug BHV-7000 for the treatment of major depressive disorder missed the primary endpoint. Trends favoring BHV-7000 were observed in some clinically relevant subgroups, including participants with more severe depression at screening and baseline, on primary and secondary outcome measures.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Nvidia (NVDA) edge higher in the premarket session as the company takes agreed to a licensing deal with artificial intelligence startup Groq, furthering its investments in companies connected to the AI boom and gaining the right to add a new type of technology to its products.
- Shares of Sidus Space (SIDU) rallied as much as 30 percent ahead of the US market open after the Cape Canaveral, Florida-based space and defense tech company announced plans to raise capital through a public offering of its Class A common stock and or pre-funded warrants.
- Shares of Biohaven (BHVN) fell as much 14 percent in US premarket trading after a mid-stage study of the company’s experimental drug BHV-7000 for the treatment of major depressive disorder missed the primary endpoint. Trends favoring BHV-7000 were observed in some clinically relevant subgroups, including participants with more severe depression at screening and baseline, on primary and secondary outcome measures.

See omnystudio.com/listener for privacy information.

- Nike (NKE) shares got a boost on Wednesday after a filing showed that Apple CEO Tim Cook purchased $2.95 million worth of shares on Dec. 22. Cook is Nike’s lead independent director and served as a director since 2005, according to the company’s website. The filing shows Cook purchased 50,000 Class B common stock at a weighted average price of $58.97.
- Costco (COST) rose after receiving an upgrade for Christmas, as Northcoast Research analyst Charles Cerankosky raised the recommendation on wholesale giant to buy from neutral. His new price target of $1,100 implies a 29% increase from Tuesday's closing price. Investors who followed Cerankosky's recommendation received a 0% return in the past year, compared with a negative 9.5% return on the shares.
- Dynavax (DVAX) popped after Sanofi agreed to buy the small biopharmaceutical firm for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise. The French drugmaker will pay $15.50 a share in cash for Dynavax, 39% above the Emeryville, California-based firm’s closing price Tuesday. The statement on Wednesday came minutes after Sanofi said the US Food and Drug Administration had surprisingly rejected its experimental multiple sclerosis drug tolebrutinib.

See omnystudio.com/listener for privacy information.

- Intel (INTC) shares fell Wednesday after a report said that Nvidia Corp. halted a test to use Intel’s production process to make advanced chips. Nvidia recently tested the so-called 18A process but stopped moving forward, Reuters reported, citing two unidentified people familiar with the matter. Spokespeople for Nvidia and Intel didn’t immediately respond to requests for comment. An Intel spokesperson told Reuters that the company’s 18A manufacturing technologies are “progressing well.”

- Dynavax (DVAX) soared after Sanofi agreed to buy the small biopharmaceutical firm for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise. The French drugmaker will pay $15.50 a share in cash for Dynavax, 39% above the Emeryville, California-based firm’s closing price Tuesday. The statement on Wednesday came minutes after Sanofi said the US Food and Drug Administration had surprisingly rejected its experimental multiple sclerosis drug tolebrutinib.

- Snowflake (SNOW) dipped after The Information reported that the software company is in talks to buy the closely held Observe Inc. for around $1 billion. Baird writes that such a deal “could make strategic sense” as a way to compete with Databricks, which “has been very acquisitive to expand its platform.”

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Intel (INTC) fell in the early session after Reuters reported that Nvidia halted a test that uses the chip manufacturer’s 18A technology to produce its chips. Nvidia recently tested whether it could manufacture its chips using Intel’s 18A production process but stopped moving forward, Reuters reported, citing two people familiar with the matter. Nvidia did not respond to Reuters’ request for comment, while an Intel spokesperson told Reuters the company’s 18A manufacturing technologies are “progressing well.”
- Shares of Dynavax Technologies (DVAX) soared in premarket trading after Sanofi agreed to buy Dynavax for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise. The French drugmaker will pay $15.50 a share in cash for Dynavax, 39% above the Emeryville, California-based firm’s closing price Tuesday. The statement on Wednesday came minutes after Sanofi said the US Food and Drug Administration had surprisingly rejected its experimental multiple sclerosis drug tolebrutinib.
- Shares of Nike (NKE) moved higher ahead of the US market open after a filing shows that Apple CEO Tim Cook purchased $2.95 million worth of shares on December 22nd. Cook is Nike’s lead independent director and served as a director since 2005, according to the company’s website.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Dynavax Technologies (DVAX) soared in premarket trading after Sanofi agreed to buy Dynavax for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise. The French drugmaker will pay $15.50 a share in cash for Dynavax, 39% above the Emeryville, California-based firm’s closing price Tuesday. The statement on Wednesday came minutes after Sanofi said the US Food and Drug Administration had surprisingly rejected its experimental multiple sclerosis drug tolebrutinib.
- Shares of Intel (INTC) fell in the early session after Reuters reported that Nvidia halted a test that uses the chip manufacturer’s 18A technology to produce its chips. Nvidia recently tested whether it could manufacture its chips using Intel’s 18A production process but stopped moving forward, Reuters reported, citing two people familiar with the matter. Nvidia did not respond to Reuters’ request for comment, while an Intel spokesperson told Reuters the company’s 18A manufacturing technologies are “progressing well.”
- Shares of AST SpaceMobile (ASTS) rallied ahead of the US market open after the company launched its largest-ever satellite from India, the first in a series of deployments to help AST compete against Elon Musk’s SpaceX in delivering space-based connectivity to mobile phones. The BlueBird 6 satellite took flight at 8:55 a.m. local time from the Satish Dhawan Space Center in southern India aboard the Indian Space Research Organization, or ISRO’s LVM3 rocket. The successful launch is a big boost for the Texas-based company as well as India’s space program which wants to build its orbital space station among other ambitious projects.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:
- BP agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion.
- French biotech company Abivax started the year with a market value of less than $500 million. After a meteoric rally, it’s now worth more than $8 billion — and some analysts see the potential for even more gains
- B&M's stock has fallen 56% in 2025, extending the previous year’s 34% drop, as the firm struggles to contend with a cocktail of rising competition, increasing wage costs and a pinch on the low-income households that have been key to its past success.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:
- BP Plc agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion.
- Sanofi agreed to buy Dynavax Technologies Corp. for about $2.2 billion, as the French drugmaker tries to expand a vaccines business currently anchored by its flu shot franchise.
- Fresnillo and other european mining stocks may be active on Wednesday as gold rises above $4,500 an ounce for the first time on escalating tensions in Venezuela and expectations for more US interest rate cuts. Silver, platinum and copper also hit records

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Novo Nordisk (NVO) shares rallied in trading today following the drugmaker getting US approval to sell a pill version of its blockbuster obesity shot Wegovy. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term. The pill is crucial for Novo’s strategy to take on Eli Lilly, which has said its own oral obesity drug could be approved by March. That would give Novo a head start of just a few months.
- ServiceNow (NOW) has reached a deal to buy the cybersecurity startup Armis in a deal valued at $7.75 billion, representing its largest acquisition to date. The Santa Clara, California-based enterprise tech company will pay in cash for San Francisco-based Armis, according to a statement Tuesday that confirmed an earlier Bloomberg News report. ServiceNow, which provides software that helps companies organize and automate their personnel and information technology operations, has become a dominant platform for enterprise workflow. In March, ServiceNow struck an agreement to buy the artificial intelligence firm Moveworks Inc. for $2.85 billion as part of its push into AI tools that can complete tasks without human supervision. Shares of the startup fell during trading on Tuesday.
- Sable (SOC) shares rose as much as 30% after the company said that the US Department of Transportation, Pipeline and Hazardous Materials Safety Administration approved the firm’s Las Flores pipeline restart plan.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Novo Nordisk (NVO) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker’s ability to compete in the obesity market it pioneered. Shares continued to rally in New York trading on Tuesday.
- Johnson & Johnson (JNJ) was ordered to pay about $1.56 billion to a Maryland woman who blamed the company’s talc-based baby powder for causing her asbestos-linked cancer, the largest such verdict for an individual in 15 years of litigation. The verdict comes as J&J has been pummeled by a recent spate of baby powder verdicts after it failed this year to use bankruptcy court to force a settlement of more than 70,000 lawsuits accusing the company of hiding the product’s cancer risks. Shares of the company fell in trading on Tuesday.
- ServiceNow (NOW) has reached a deal to buy the cybersecurity startup Armis in a deal valued at $7.75 billion, representing its largest acquisition to date. Shares in ServiceNow fell about 1.3% in early trading before markets opened in New York. They closed up around 0.9% on Monday, giving the company a market valuation of about $163 billion.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Novo Nordisk (NOVOB) won approval to sell a pill version of its obesity shot Wegovy in the US, to help people lose weight or maintain previous weight loss over the long term. The company will start selling the pill in the US in early January, and it is approved based on the results of the Oasis 4 trial, which found people taking the pill lost about 13.6% of their body weight over 64 weeks.
- Johnson & Johnson (JNJ) was ordered to pay about $1.56 billion to a Maryland woman who blamed the company's talc-based baby powder for causing her asbestos-linked cancer.
- ServiceNow Inc. has reached a deal to buy the cybersecurity startup Armis in a deal valued at $7.75 billion, representing its largest acquisition to date. Shares have fallen over 4% on the news.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Novo Nordisk (NOVOB) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly (LLY). The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker’s ability to compete in the obesity market it pioneered.
- Copper hit a fresh all-time high above $12,000 a ton due to severe mine outages and trade dislocations linked to US President Donald Trump’s tariff agenda. Shares of Albemarle climbed as a result.
- The US Navy announced plans to build a new class of warship, the FF(X), as part of President Donald Trump's "Golden Fleet" bid to revive US shipbuilding. That caused shares of Huntington Ingalls Industries Inc. to rise.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term.
- Shares of naval shipmaker Huntington Ingalls (HII) rallied ahead of the US market open after President Trump announced the Navy will build a new “Trump-class” battleship as part of the White House push to modernize a fleet that’s been hobbled by years of cost overruns and delays.
- Shares of Copenhagen-listed Orsted (ORSTED DC) declined after the company said it’s considering “all options” including legal action as it weighs how to respond to a US decision to suspend leases for five offshore wind farms, according to a statement late Monday. Orsted said its farms — Revolution Wind and Sunrise Wind — had secured all the required federal and state permits, including consulting “closely and directly” with US authorities to “to evaluate and address potential impacts to national security and defense capabilities.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term.

- Shares of naval shipmaker Huntington Ingalls (HII) rallied ahead of the US market open after President Trump announced the Navy will build a new “Trump-class” battleship as part of the White House push to modernize a fleet that’s been hobbled by years of cost overruns and delays.

- Shares of Warner Bros. Discovery (WBD) edged higher in the early session as Larry Ellison is throwing his personal fortune behind Paramount Skydance Corp.’s bid for WBD, aiming to give his son’s company an advantage in a fiercely contested takeover battle with Netflix Inc.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:

- Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly.

- Ryanair was fined more than €255 million ($300 million) by Italy’s antitrust watchdog for allegedly using an “abusive strategy” to thwart third-party travel agencies.

- Cevian Capital raises its total holding in Akzo Nobel NV to 10.15% from ~5%, according to a filing with the Dutch financial authority AFM.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:

- Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly.

- Orsted said it’s considering “all options” including legal action as it weighs how to respond to a US decision to suspend leases for five offshore wind farms, according to a statement late Monday.

- Pets at Home Group named James Bailey, the former managing director of upmarket grocer Waitrose, as its new chief executive officer to lead a reboot of the struggling pet care company. 

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Warner Bros. Discovery (WBD) shares rallied in trading today after word that Larry Ellison is throwing his personal fortune behind Paramount Skydance Corp.’s bid for it, aiming to give his son’s company an advantage in a fiercely contested takeover battle with Netflix. Paramount has been aggressively pursuing Warner Bros. for months and Ellison was taken by surprise when the board agreed to a deal with Netflix for $82.7 billion for the streaming and studio assets. The strength of the financing for each bid has emerged as a decisive issue in the takeover battle, which unleashed two massive debt-fueled offers that rank among the largest in the past decade. Paramount took its offer of $30 a share, or $108.4 billion including debt, for the entire company directly to shareholders. Warner Bros. shares gained 3.4% in New York afternoon trading, and changed hands during the session for as much as $28.98. Paramount rose as much as 8.1% while Netflix dropped about 1%.
- First Solar (FSLR) rose as much as 7.1%, touching the highest intraday since June 2024, after news Alphabet will buy clean-energy developer Intersect Power in one of the company’s biggest deals aimed at boosting its AI-related data-center footprint. The stock was the top S&P 500 gainer with less than 10 minutes to the close. Other solar names with gains in Monday trading included: Canadian Solar up as much as 15%; Array Technologies rises as much as 10%; Nextpower +7.7%.
- Clearwater Analysts (CWAN) shares are up 8.5% on Monday, after a group of private equity firms agreed to buy the investment and accounting software company in a deal valuing it at $8.4 billion. Analysts said the deal price was lower than expected.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Warner Bros. Discovery (WBD) shares rose on news that Larry Ellison is throwing his personal fortune behind Paramount Skydance’s bid for it, aiming to give his son’s company an advantage in a fiercely contested takeover battle with Netflix. Both suitors moved on Monday to strengthen the financial backing for their offers, though they stopped short of increasing their bids. Netflix refinanced a portion of its planned $59 billion of debt as a way to ensure a lasting investment-grade rating — a key advantage it holds over the lower-rated Paramount. Warner Bros. shares gained 3.4% in New York afternoon trading, and changed hands during the session for as much as $28.98. Paramount rose as much as 8.1% while Netflix dropped about 1%.
- First Solar (FSLR) rose as much as 6.2%, touching the highest intraday since June 2024, after news Alphabet will buy clean-energy developer Intersect Power in one of the company’s biggest deals aimed at boosting its AI-related data-center footprint.
- Navan (NAVN) shares climb as much as 12% after the business travel and expense management software maker announced that it had been added to the broad-market Russell 3000 Index and the small-cap Russell 2000 Index, as of Monday’s opening bell.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Warner Bros Discovery (WBD) shares are up 3.9% in premarket trading after Larry Ellison agreed to provide an irrevocable personal guarantee of $40.4 billion of the equity financing for the offer and any damages claims against Paramount. Paramount Skydance rises 3.1%, while Netflix ticks 0.4% higher.
- Marvell Technology (MRVL) shares are up 2.1% in premarket trading, after Citi opened a positive catalyst watch on the chipmaker ahead of next month’s CES conference.
- Rocket Lab (RKLB) shares jumped 18% on Friday and closed at a record high of $70.52 after the U.S. Space Development Agency on Friday awarded the company an agreement worth up to $805 million to provide 18 missile warning, tracking and defense satellites. Rocket Lab said the agreement was its largest single contract to date.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Warner Bros Discovery shares are up 3.9% in premarket trading after Larry Ellison agreed to provide an irrevocable personal guarantee of $40.4 billion of the equity financing for the offer and any damages claims against Paramount. Paramount Skydance rises 3.1%, while Netflix ticks 0.4% higher.
- Nelson Peltz’s Trian Fund Management and General Catalyst agreed to buy asset manager Janus Henderson Group (JHG) for about $7.4 billion. Shareholders will receive $49 a share in cash, up from $46 a share that the investors offered in October, according to a statement Monday. Trian already owns 20.6% of Janus Henderson’s shares.
- Shares of Newmont (ASX:NEM) rose over 5% in recent trade and reached their all-time peak in recent trading on the Australian bourse on Monday after gold touched a fresh record on expectations of US rate cuts.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Warner Bros. Discovery (WBD) moved higher ahead of the US market open as Paramount Skydance Corp. sweetened its bid for WBD, including offering a personal financial guarantee by Oracle Corp. Chairman Larry Ellison, as it seeks to beat out a rival bid from Netflix Inc. Ellison has agreed to personally guarantee $40.4 billion in equity financing for Paramount’s proposed $108.4 billion offer for Warner Bros., according to a statement Monday.  Ellison, whose son David Ellison is chief executive officer of Paramount, agreed not to revoke the Ellison family trust.
- Shares of Rocket Lab (RKLB) climbed in early trading after the company won a US Space Force contract to design and build 18 satellites, marking the company’s largest single contract to date. The deal includes additional subsystem opportunities that could take the contract's total value to about $1 billion.
- Shares of Clearwater Analytics (CWAN) rallied in premarket trading as a group of private equity firms led by Permira and Warburg Pincus has agreed to acquire Clearwater in a deal valuing the investment and accounting software maker at $8.4 billion including debt. Clearwater investors would get $24.55 a share for an equity value of about $7 billion, according to a statement confirming an earlier report by Bloomberg News. The company said the price, which is roughly 10% higher than the stock’s last close, represents a 47% premium to the price on Nov. 10, before Bloomberg reported the two buyout firms were in talks to buy it.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Netflix (NFLX) has refinanced part of a $59 billion bridge loan to support its potential acquisition of Warner Bros. Discovery Inc.
The streaming giant secured a $5 billion revolving credit facility and two $10 billion delayed-draw term loans to refinance part of the bridge facility it took out for its Warner Bros. bid, according to a filing on Monday. That leaves $34 billion for syndication.

- Shares of Clearwater Analytics (CWAN) rallied in premarket trading as a group of private equity firms led by Permira and Warburg Pincus has agreed to acquire Clearwater in a deal valuing the investment and accounting software maker at $8.4 billion including debt. Clearwater investors would get $24.55 a share for an equity value of about $7 billion, according to a statement confirming an earlier report by Bloomberg News. The company said the price, which is roughly 10% higher than the stock’s last close, represents a 47% premium to the price on Nov. 10, before Bloomberg reported the two buyout firms were in talks to buy it.

- Shares of Datavault AI (DVLT) soared ahead of the US market open after the company announced the issuance of two U.S. patents supporting its push into AI-powered data monetization and blockchain-based content licensing. The patents, which enable automated smart contract enforcement and tokenized royalty distribution, bolster the company’s position in the $369 billion global content licensing market.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:
- BHP and other miners are up as gold rose to an all-time high, as escalating geopolitical tensions and bets on further US rate cuts added momentum to the best annual performance in more than four decades.
- Dairy makers are being hit after news that China will impose preliminary anti-subsidy duties of 21.9% to 42.7% on certain dairy products imports from the European Union from Dec. 23, according to a Ministry of Commerce statement.
- Harbour Energy agreed to acquire LLOG Exploration Co. for $3.2 billion, marking the UK company’s entry into the deepwater US Gulf of Mexico.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:
- Telecom Italia’s board approved a proposal to convert the company’s savings shares into ordinary stock and to reduce its share capital, moving toward a long-delayed change that would simplify its capital structure.
- Fresnillo and other miners are up as gold rose to an all-time high, as escalating geopolitical tensions and bets on further US rate cuts added momentum to the best annual performance in more than four decades.
- Harbour Energy agreed to acquire LLOG Exploration Co. for $3.2 billion, marking the UK company’s entry into the deepwater US Gulf of Mexico.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Computer data storage companies SanDisk (SNDK) and Micron (MU) both saw a boost to their share prices, coinciding with the rise of AI and computer technology spaces

- Rivian (RIVN) sees their stock price climb 10.7% with anticipation for the release of the R2, their mid-size SUV

- Frozen potato product brand Lamb Weston (LW) dropped 26% after a consistent decline and the company re-affirming its guidance

See omnystudio.com/listener for privacy information.

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Tim Stenovec and Carol Massar.

On this episode of Stock Movers:

- Cruise group Carnival (CCL) sees their share price jump by over 9% today as the company expects profits to increase next year

- WhiteFiber (WYFI) shares rose after it announced a 10-year 40 megawatt co-location agreement between its subsidiary Enovum Data Centers Corp. and Nscale Global Holdings, representing around $865 million in contracted revenue. 

- KB Home (KBH) saw their stock decrease by 8.5% after posting fiscal 4th quarter revenue that missed analyst estimates

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Oracle (ORCL) sees a 7% boost after it was announced that they would be leading a group of buyers in purchasing TikTok.

- Nike (NKE) is down for the fourth day in a row with an 11% drop today. Sales are continuing to decline, citing difficulty in China as well as their Converse brand.

- BioMarin Pharmaceutical (BMRN) is up big at 17% with their agreement to buy Amicus Pharmaceutics, helping expand their treatments for rare diseases.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Nike (NKE) shares sink after the company warned that sales will decline this quarter amid persistent weakness in China and at its Converse brand. The world’s largest sportswear company expects revenue to be down in the low-single digits in the three months that started Dec. 1, a surprising turn after two straight periods of growth.
- FedEx (FDX) shares fall the most intraday since June 25, as the shipping firm upgraded FY targets, but to a lower magnitude than the 2Q earnings beat as it suffers from a string of cost headwinds including the grounding of its MD-11 planes.
- KB Home (KBH) shares fall. The homebuilder posted fiscal fourth-quarter profit that missed analysts’ estimates. The mid-point of the outlook range for fiscal 2026 housing revenue also lagged expectations.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- BioMarin (BMRN) shares rise after the company agreed to buy Amicus Therapeutics Inc. for about $4.8 billion, helping the biotech company expand its portfolio of treatments for rare diseases.
- FedEx (FDX) shares fall the most intraday since June 25, as the shipping firm upgraded FY targets, but to a lower magnitude than the 2Q earnings beat as it suffers from a string of cost headwinds including the grounding of its MD-11 planes.
- Nike (NKE) shares sink after the company warned that sales will decline this quarter amid persistent weakness in China and at its Converse brand. The world’s largest sportswear company expects revenue to be down in the low-single digits in the three months that started Dec. 1, a surprising turn after two straight periods of growth.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Nike (NKE) fell as much as 10 percent in premarket trading as the sportswear retailer’s third-quarter guidance disappointed investors, with its turnaround hampered by weak sales in China and the Converse brand. It expects third-quarter sales to be down low-single digits, and gross margins to shrink by roughly 2 percentage points due to tariffs. North America business — a bright spot for fiscal 2Q — is expected to grow more slowly in the third quarter as product liquidation will no longer provide a big sales boost.
- Shares of FedEx (FDX) edged lower in the early session as the shipping firm upgraded FY targets, but to a lower magnitude than the 2Q earnings beat as it suffers from a string of cost headwinds including the grounding of its MD-11 planes. Analysts are mostly positive on 2Q results that are boosted by peak season demand, cost reductions and customer wins in B2B health care. The non-core freight division that’s scheduled to be spun off remains under pressure.
- Shares of Oracle (ORCL) rallied ahead of the US market open as TikTok’s long-delayed plan to separate from Chinese parent ByteDance Ltd. was put in motion Thursday when the video sharing sensation said it’s being bought by a group of buyers, led by Oracle. TikTok Chief Executive Officer Shou Chew told employees that the company and ByteDance signed binding agreements to create a US joint venture majority-owned by American investors, according to an internal memo reviewed by Bloomberg. Chew wrote that he was “pleased to share some great news” and said agreements with Oracle, Silver Lake Management and MGX have been signed. The deal is expected to close on Jan. 22, 2026, though Chew added that “there’s more work to be done” before then. Chinese regulators have yet to say whether they’ll approve the transaction.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Shares of Nike (NKE) fell as much as 10 percent in premarket trading as the sportswear retailer’s third-quarter guidance disappointed investors, with its turnaround hampered by weak sales in China and the Converse brand. It expects third-quarter sales to be down low-single digits, and gross margins to shrink by roughly 2 percentage points due to tariffs. North America business — a bright spot for fiscal 2Q — is expected to grow more slowly in the third quarter as product liquidation will no longer provide a big sales boost.

- Shares of Oracle (ORCL) rallied ahead of the US market open as TikTok’s long-delayed plan to separate from Chinese parent ByteDance Ltd. was put in motion Thursday when the video sharing sensation said it’s being bought by a group of buyers, led by Oracle. TikTok Chief Executive Officer Shou Chew told employees that the company and ByteDance signed binding agreements to create a US joint venture majority-owned by American investors, according to an internal memo reviewed by Bloomberg. Chew wrote that he was “pleased to share some great news” and said agreements with Oracle, Silver Lake Management and MGX have been signed. The deal is expected to close on Jan. 22, 2026, though Chew added that “there’s more work to be done” before then. Chinese regulators have yet to say whether they’ll approve the transaction.

- Shares of FedEx (FDX) edged lower in the early session as the shipping firm upgraded FY targets, but to a lower magnitude than the 2Q earnings beat as it suffers from a string of cost headwinds including the grounding of its MD-11 planes. Analysts are mostly positive on 2Q results that are boosted by peak season demand, cost reductions and customer wins in B2B health care. The non-core freight division that’s scheduled to be spun off remains under pressure.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:
- WH Smith is under investigation by the UK’s Financial Conduct Authority over the accounting error in its North American business that triggered a stock slump and the resignation of its chief executive officer.
- BBVA SA said it will carry out its largest share buyback ever as it seeks to draw a line under its failed bid for Banco Sabadell.
- Ipsen shares drop as much as 3.8%, the worst performance in the Stoxx 600 Health Care Index on Friday morning, after the company said a mid-stage trial evaluating its experimental oral drug for an ultra-rare bone disease did not meet its primary endpoint.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:
- Renault has regained its investment-grade status at S&P Global Ratings. UBS rates Arcadis and Rieter neutral. On Tradegate, Rolls-Royce and Ads-Tec Energy are among the most active industrials stocks before European markets open, gaining 1.2% and falling 8.2% respectively.
- European sportswear stocks could be active on Friday after Nike warned sales will decline this quarter due to weakness in China and its Converse brand
- WH Smith is under investigation by the UK’s Financial Conduct Authority over the accounting error in its North American business that triggered a stock slump and the resignation of its chief executive officer.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Micron (MU) kicked off its biggest single-day stock gain in more than eight months after delivering an upbeat forecast for the current quarter, signaling that surging demand and supply shortages are allowing the memory-chip maker to charge more for products.
- Nike (NKE) posted more weakness in China and its Converse brand, sending shares down and offsetting higher-than-expected revenue in the latest quarter. Direct-to-consumer sales missed expectations, while Converse plunged 30% in the fiscal second quarter ended Nov. 30. Revenue rose 1% to $12.4 billion, above the average of analyst estimates.
- FedEx Corp. (FDX) raised the low end of its full-year profit and sales outlook, signaling the company’s efforts to slash costs and streamline its delivery networks are bearing fruit as demand improvesSebastian Escobar

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Cannabis stocks like Tilray (TLRY) and Canopy (CGC) fell Thursday after President Donald Trump signed an executive order to reschedule marijuana as a lower-class drug. Trump's order reclassifies marijuana as a Schedule III drug from Schedule I, but doesn't permit legalized recreational sales. Other Schedule I substances include highly addictive drugs with no accepted medical use, such as heroin, while Schedule III substances are considered to have lower potential for abuse.

- Birkenstock (BIRK) shares drop after the company predicted a slower pace of sales growth in the coming year as its sandals and clogs contend with the impact of a weaker US dollar and tariffs.

- Shares of Lululemon (LULU) jumped after activist investor Elliott Investment Management has built a stake of more than $1 billion in Lululemon. Elliott has been working with retail executive Jane Nielsen, who is viewed as a potential CEO candidate, as the company searches for a replacement for current CEO Calvin McDonald.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Cannabis stocks like Tilray (TLRY) and Canopy (CGC) fell Thursday after President Donald Trump signed an executive order to reschedule marijuana as a lower-class drug. Trump's order reclassifies marijuana as a Schedule III drug from Schedule I, but doesn't permit legalized recreational sales. Other Schedule I substances include highly addictive drugs with no accepted medical use, such as heroin, while Schedule III substances are considered to have lower potential for abuse.
- Shares of Micron Technology (MU) the largest US maker of computer memory chips, rose by the most in eight months after the company gave an upbeat forecast for the current quarter, signaling that surging demand and supply shortages are allowing the company to charge more for products.
- Shares of Lululemon (LULU) jumped after activist investor Elliott Investment Management has built a stake of more than $1 billion in Lululemon. Elliott has been working with retail executive Jane Nielsen, who is viewed as a potential CEO candidate, as the company searches for a replacement for current CEO Calvin McDonald.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Accenture (ACN) shares fall after the IT services company gave an outlook that analysts said pointed to slower growth. It also reported first-quarter results that are seen as strong.
- Birkenstock (BIRK) shares drop after the company predicted a slower pace of sales growth in the coming year as its sandals and clogs contend with the impact of a weaker US dollar and tariffs.
- CarMax (KMX) shares rise after said it will tolerate lower margins and boost ad spending to repair its business and attract buyers after slumping sales wiped out half of the used car retailer’s market value this year.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Instacart (CART) is down after Reuters reported that the Federal Trade Commission has sent the grocery delivery company a civil investigative demand.
- Lululemon (LULU) rises on reports that activist investor Elliott Investment Managementhas built a stake of more than $1 billion in the athletic apparel retailer.
- Micron (MU) jumps after providing an upbeat forecast for the current quarter, citing surging demand and supply shortages that are allowing the company to charge more for products.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Trump Media & Technology Group Corp (DJT) soared ahead of the US market open after the company behind Truth Social announced that it agreed to merge with clean fusion energy company TAE Technologies in an all-stock transaction valued at more than $6 billion.
- Shares of Micron Technology (MU) moved higher in premarket trading after the company gave an upbeat forecast for the current quarter, a sign that surging demand and supply shortages are allowing the company to charge more for products. Fiscal second-quarter revenue will be $18.3 billion to $19.1 billion, the company said in a statement Wednesday. Analysts had estimated $14.4 billion on average for the period. Excluding some items, profit will be $8.22 to $8.62 a share, compared with a projection of $4.71. Micron is the largest US maker of computer memory chips.
- Shares of Lululemon Athletica (LULU) rallied after reports activist investor Elliott Investment Management has built a stake of more than $1 billion in the athleisure maker, according to people familiar. Elliott has been working for months with retail executive Jane Nielsen — a former chief financial officer and chief operating officer at Ralph Lauren — on Lululemon, said the person, who asked to remain unnamed as the matter is private.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of Trump Media & Technology Group Corp (DJT) soared ahead of the US market open after the company behind Truth Social announced that it agreed to merge with clean fusion energy company TAE Technologies in an all-stock transaction valued at more than $6 billion.
- Shares of Micron Technology (MU) rallied in premarket trading after the company gave an upbeat forecast for the current quarter, a sign that surging demand and supply shortages are allowing the company to charge more for products. Fiscal second-quarter revenue will be $18.3 billion to $19.1 billion, the company said in a statement Wednesday. Analysts had estimated $14.4 billion on average for the period. Excluding some items, profit will be $8.22 to $8.62 a share, compared with a projection of $4.71. Micron is the largest US maker of computer memory chips.
- Accenture (ACN) reported adjusted earnings per share for the first quarter that beat the average analyst estimate.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:
- BP Plc appointed Meg O’Neill as chief executive officer, replacing Murray Auchincloss after just two years in the job as the oil giant struggles to revive its fortunes following a botched pivot toward renewables.
- Whitbread shares rally as much as 4.5%, Thursday’s biggest gainer in the FTSE 100. Corvex Management announced it has accumulated a 6.05% ownership stake in the hotel operator and is calling for a strategic review of the company.
- Rheinmetall shares were little changed after the firm adjusted its full-year outlook, in a move Morgan Stanley says represents an increase to sales growth at the group level, but a reduction on a standalone defense basis.

See omnystudio.com/listener for privacy information.

On This episode of Stock Movers:
- BP Plc appointed Meg O’Neill as chief executive officer, replacing Murray Auchincloss after just two years in the job as the oil giant struggles to revive its fortunes following a botched pivot toward renewables.
- Evolution drops as much as 3.1% following a double-downgrade to underweight from overweight at Barclays, which sees continued pressure on the Swedish gambling operator’s earnings.
- Currys PLC on Thursday reported an acceleration in sales growth during the first half of its financial year and declared a dividend after passing on a payment last year.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- General Mills (GIS) shares rise 1.6% after the food company’s second-quarter results beat Street expectations. A highlight of the report was positive volume growth in the North America Retail segment. The company maintained its annual guidance ranges, despite the beat, given persistent consumer pressures.
- Oracle (ORCL) shares are down 5.3% on Wednesday, after the Financial Times reported that Blue Owl Capital will not back a $10 billion deal for the software giant’s next data center. Subsequently, an Oracle spokesperson said that Blue Owl is out of the data center deal, but that it remains on schedule.
- Canaccord downgraded Udemy (UDMY) to Hold from Buy with a $7 price target after the company announced a merger with Coursera

See omnystudio.com/listener for privacy information.

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Tim Stenovec and Carol Massar.
On this episode of Stock Movers:
- Micron (MU) the largest US maker of computer memory chips, gave an upbeat forecast for the current quarter, a sign that surging demand and supply shortages are allowing the company to charge more for products. Fiscal second-quarter revenue will be $18.3 billion to $19.1 billion, the company said in a statement Wednesday. Analysts had estimated $14.4 billion on average for the period. Excluding some items, profit will be $8.22 to $8.62 a share, compared with a projection of $4.71. Micron shares rose about 4% in late trading after the results were released. The stock was already up 168% this year, closing at $225.71 on Wednesday.
- Medline (MDLN) shares surged 41% in their trading debut, after the medical supplier raised $6.26 billion in the year’s biggest initial public offering. The shares closed at $41 each on Wednesday in New York, versus the IPO price of $29. Medline, which counts Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman among its backers, sold 216 million shares in an upsized offering that priced near the top of the marketed range. The trading gives the company a market value of about $55 billion, based on the shares listed in its regulatory filings.
- Nvidia (NVDA) settled a lawsuit involving a former engineer who had inadvertently revealed autonomous driving trade secrets that he stole from a previous employer. The accord between the Silicon Valley artificial intelligence giant and a German unit of Paris-based Valeo SE was disclosed in a filing in federal court in San Jose, California. No details of the agreement were provided. A trial set for next month was canceled. Nvidia shares were lower in trading on Wednesday.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Oracle (ORCL) shares are down 5.3% on Wednesday, after the Financial Times reported that Blue Owl Capital will not back a $10 billion deal for the software giant’s next data center. Subsequently, an Oracle spokesperson said that Blue Owl is out of the data center deal, but that it remains on schedule.
- Lennar (LEN) shares fall 3.8% in premarket trading after the homebuilder forecast 1Q orders, deliveries and margins all below expectations, signaling strains on the housing market despite a lower interest rate. The builder also posted lower-than-expected orders and margins for 4Q. Keep an eye on shares of peers including DR Horton, PulteGroup and Toll Brothers.
- Medline (MDLN) shares surged 30% in their trading debut, after the medical supplier raised $6.26 billion in the year’s biggest initial public offering.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Lennar (LEN) shares fall. Builder Lennar Corp.’s forecast for quarterly home orders missed analysts’ estimates as affordability pressures and the weakening job market pushes buyers to the sidelines. The company projected 18,000 to 19,000 signed contracts for its fiscal first quarter, according to a statement Tuesday. Analysts expected 20,297, the average in a survey compiled by Bloomberg.
- Frontier Group (ULCC) shares rise. Bankrupt Spirit Aviation Holdings Inc. is in revived discussions to merge with Frontier Group Holdings, people familiar with the matter said, in a deal that could rescue the deep-discount airline from insolvency at a time of stiff competition from larger US carriers.
- Oracle (ORCL) shares fall after the company said final negotiations on an equity deal for a data center project in Michigan are “on schedule” and doesn’t include Blue Owl Capital, a firm that has helped finance massive data center projects for firms including Oracle and Meta Platforms Inc. in recent months.

See omnystudio.com/listener for privacy information.